Home Editorial The Urgency of Ending Malaria in Nigeria

The Urgency of Ending Malaria in Nigeria

0
21

 

On 25 April, the world marked World Malaria Day 2026 under the theme, “Driven to End Malaria: Now We Can. Now We Must.” For Nigeria, this message deserves to be treated as more than a yearly observance. It should be read as a clear national challenge. The time for hesitant, piecemeal responses has passed. What is needed now is a determined and sustained effort, pursued with discipline, seriousness and continuity.

Nigeria remains the country most affected by malaria in the world. It accounts for roughly one in every four global cases and nearly one in three deaths. Each year, this translates into more than 68 million infections and close to 200,000 deaths. Malaria is responsible for around 30 per cent of hospital admissions and continues to weaken household finances, disrupt education, reduce productivity and place pressure on already stretched health facilities. No country seeking growth and stability can afford to treat such a burden as routine.

The economic consequences are substantial. The Coordinating Minister of Health and Social Welfare, Ali Pate, has estimated that malaria costs Nigeria about $1.1 billion annually. The human cost is even more devastating. “In 2022, over 180,000 Nigerian children under the age of five lost their lives to malaria,” Pate lamented. Such figures should stir the conscience of the nation. They demand more than sympathy; they require decisive policy attention.

There is, however, a window of opportunity that Nigeria must not waste. Scientific progress has changed the equation. Advances in science have strengthened the fight against malaria. Vaccines are now being introduced, treatments are more effective, and mosquito-control tools continue to improve. The World Health Organisation has said that ending malaria within our lifetime is now a realistic possibility. However, progress depends on whether nations can convert medical advances into functioning systems that reach those most at risk.

This is where the government must confront a stark truth. Our difficulty has often not been the absence of plans, but the weakness of execution. Millions of insecticide-treated nets have been supplied, yet actual usage remains uneven. Government and its partners must look beyond quantities delivered and insist on measurable outcomes. Behavioural change campaigns should no longer be treated as an afterthought. They must be planned with the same care given to procurement and logistics. Community leaders, religious bodies, and trusted local voices should be deliberately enlisted to reinforce preventive habits and prompt treatment-seeking behaviour.

Encouragingly, initiatives such as the Geneith Health Competition point in the right direction by placing young people at the centre of the response. The Managing Director of CEOAFRICA, Cletus Iloabanafor, has rightly drawn attention to Nigeria’s disproportionate burden, while, alongside Emmanuel Umenwa, founder and CEO of Geneith Pharmaceuticals Limited, calling on youth to serve as “Ambassadors of War Against Malaria.” That call should not end as rhetoric. The government should formally integrate youth-led advocacy into national malaria strategies, fund it, and hold it accountable for measurable results.

At the highest level, the First Lady, Oluremi Tinubu, has also stressed the need for stronger prevention and wider access. “Let us strengthen prevention efforts, support life-saving interventions, and ensure that every community, especially the most vulnerable, has access to the materials needed to prevent and treat malaria,” she recently said. Her emphasis is well placed. Yet access must be dependable, not occasional. Supplies must reach communities promptly, primary healthcare centres must remain functional, and health workers must be equipped to diagnose and treat cases without delay.

Funding is where commitment is most clearly tested. Nigeria cannot continue to rely heavily on external donors. The federal government should include malaria funding within the national budget and ensure the timely release of funds. States, too, must move from passive recipients to active financiers of health programmes. The private sector should be incentivised to invest, not only through corporate social responsibility, but through structured partnerships that support local manufacturing of nets, medicines, and diagnostics.

While investment in research and innovation remains germane, there is also a need for stronger accountability. Data must guide decisions, and performance must be measured transparently. Programmes that do not deliver results should be restructured or discontinued. Universities and research institutes must be funded to develop simpler diagnostics and new treatments, while local production of malaria tools is expanded to cut imports and stabilise supply. Traditional medicine should also be scientifically studied to identify effective compounds.

Meanwhile, emerging threats such as drug and insecticide resistance, as well as invasive mosquito species, require constant vigilance. Nigeria must not wait for these challenges to escalate before responding. Surveillance systems should be strengthened, and contingency plans must be in place to protect recent gains.

LEAVE A REPLY

Please enter your comment!
Please enter your name here